AM-Pharma B.V.

10.08.2006 – 11:03
Dutch Biopharmaceutical Company AM-Pharma Strengthens Intellectual Property Position for Lactoferrin Derived Antimicrobial Peptide hLF1-11
Bunnik, The Netherlands (ots/PRNewswire) - AM-Pharma B.V., a biopharmaceutical company engaged in the pre-clinical and early clinical development of novel compounds to treat infectious and inflammatory diseases, announces the issuance of the patent for one of its lead products, the antimicrobial peptide hLF1-11, ...
mehr
31.10.2005 – 09:58
Biopharmaceutical AM-Pharma Announces Successful Financing
Bunnik, The Netherlands (ots/PRNewswire) - - Three Lead Compounds are Progressing Into Next Clinical Phase AM-Pharma B.V., a privately owned biopharmaceutical company, engaged in the pre-clinical and early clinical development of novel compounds to treat infectious and inflammatory diseases and their consequences, announces that a major B-financing round has been successfully completed. The company attracted ...
mehr